Business Description
SHL Telemedicine Ltd
ISIN : IL0010855885
Total Employee Number:
526Compare
Compare
Traded in other countries / regions
SHLTN.Switzerland0QMX.UKSHMLF.USA IPO Date
2000-11-15Description
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.93 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.3 | |||||
Debt-to-EBITDA | -2.17 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -1.04 | |||||
Beneish M-Score | -3.22 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2 | |||||
3-Year EPS without NRI Growth Rate | 7.1 | |||||
3-Year FCF Growth Rate | 9.4 | |||||
3-Year Book Growth Rate | -21.5 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 23.38 | |||||
9-Day RSI | 36.48 | |||||
14-Day RSI | 41.79 | |||||
3-1 Month Momentum % | -6.19 | |||||
6-1 Month Momentum % | -20.18 | |||||
12-1 Month Momentum % | -10.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.25 | |||||
Quick Ratio | 1.2 | |||||
Cash Ratio | 0.87 | |||||
Days Inventory | 15.01 | |||||
Days Sales Outstanding | 49.91 | |||||
Days Payable | 47.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.6 | |||||
Shareholder Yield % | -19.44 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 46.97 | |||||
Operating Margin % | -7.7 | |||||
Net Margin % | -26.1 | |||||
EBITDA Margin % | -10.17 | |||||
FCF Margin % | -8.35 | |||||
OCF Margin % | -3.14 | |||||
ROE % | -36.68 | |||||
ROA % | -18.3 | |||||
ROIC % | -6.11 | |||||
3-Year ROIIC % | 13.44 | |||||
ROC (Joel Greenblatt) % | -133.08 | |||||
ROCE % | -24.2 | |||||
Years of Profitability over Past 10-Year | 4 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.75 | |||||
PB Ratio | 1.15 | |||||
Price-to-Tangible-Book | 4.5 | |||||
EV-to-EBIT | -2.79 | |||||
EV-to-EBITDA | -6.28 | |||||
EV-to-Revenue | 0.64 | |||||
EV-to-FCF | -7.65 | |||||
Price-to-GF-Value | 0.41 | |||||
Price-to-Projected-FCF | 1.89 | |||||
Price-to-Median-PS-Value | 0.27 | |||||
Earnings Yield (Greenblatt) % | -35.84 | |||||
FCF Yield % | -9.85 | |||||
Forward Rate of Return (Yacktman) % | -49.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SHL Telemedicine Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 47.229 | ||
| EPS (TTM) (CHF) | -0.576 | ||
| Beta | 1.4871 | ||
| 3-Year Sharpe Ratio | -0.6 | ||
| 3-Year Sortino Ratio | -0.94 | ||
| Volatility % | 86.3 | ||
| 14-Day RSI | 41.79 | ||
| 14-Day ATR (CHF) | 0.056332 | ||
| 20-Day SMA (CHF) | 0.9675 | ||
| 12-1 Month Momentum % | -10.08 | ||
| 52-Week Range (CHF) | 0.384999 - 1.485 | ||
| Shares Outstanding (Mil) | 37.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SHL Telemedicine Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SHL Telemedicine Ltd Stock Events
| Event | Date | Price (CHF) | ||
|---|---|---|---|---|
| General meeting for 2025 | 2026-05-28 13:00 | 0.96 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-04-24 | 1.05 (-3.67%) | ||
| Fourth quarter earnings results for 2025 | 2026-04-24 | 1.05 (-3.67%) | ||
| Annual report for 2025 | 2026-04-23 | 1.05 (-0.47%) | ||
| Second quarter earnings results for 2025 | 2025-09-26 | 0.60 (+11.11%) | ||
| General meeting for 2024 | 2025-05-28 13:00 | 1.08 (+0.00%) | ||
| Fourth quarter earnings conference call for 2024 | 2025-04-24 | 1.14 (+11.23%) | ||
| Fourth quarter earnings results for 2024 | 2025-04-24 | 1.14 (+11.23%) | ||
| Annual report for 2024 | 2025-04-23 | 1.13 (-4.21%) | ||
| Second quarter earnings results for 2024 | 2024-09-26 | 1.67 (+0.00%) |
Show
Entries
SHL Telemedicine Ltd Frequently Asked Questions
What is SHL Telemedicine Ltd(XSWX:SHLTN)'s stock price today?
The current price of XSWX:SHLTN is CHF1.08. The 52 week high of XSWX:SHLTN is CHF1.49 and 52 week low is CHF0.38.
When is next earnings date of SHL Telemedicine Ltd(XSWX:SHLTN)?
The next earnings date of SHL Telemedicine Ltd(XSWX:SHLTN) is 2026-09-26 Est..
Does SHL Telemedicine Ltd(XSWX:SHLTN) pay dividends? If so, how much?
SHL Telemedicine Ltd(XSWX:SHLTN) does not pay dividend.
Press Release
Articles on SHL Telemedicine Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers